Multiple Sclerosis Clinical Trials near Detroit, MI
15 studies for Multiple Sclerosis are recruiting at 19 sites within 50 miles of Detroit, Michigan, according to ClinicalTrials.gov data processed .
Distances are city-level approximations. See all Multiple Sclerosis trials in the US or all trials near Detroit.
Recruiting now
Multiple Sclerosis studies enrolling near Detroit
- A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
NCT06433752
- Observational
- Ages 18 years and older
- Sex: All
Nearest sites: TG Therapeutics Investigational Trial Site (Detroit, MI); TG Therapeutics Investigational Trial Site (Farmington, MI)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 4 sites within 50 mi
- Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
NCT04047628
- Phase 3
- Ages 18 to 55 years
- Sex: All
Nearest site: Henry Ford Neuroscience Institute (Detroit, MI)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
NCT04458688
- Observational
- Ages 18 to 60 years
- Sex: All
Nearest site: Wayne State University (Detroit, MI)
- Distance to nearest recruiting site
- <1 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
NCT06782490
- Phase 2
- Ages 18 to 70 years
- Sex: All
Nearest site: Northwest Neurology (Southfield, MI)
- Distance to nearest recruiting site
- ~13 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
NCT07623668
- Phase 3
- Ages 18 to 50 years
- Sex: All
Nearest site: Kahana Oculoplastic and Orbital Surgery (Livonia, MI)
- Distance to nearest recruiting site
- ~16 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
NCT05877963
- Phase 3
- Ages 18 to 65 years
- Sex: All
Nearest site: TG Investigational Site (Farmington, MI)
- Distance to nearest recruiting site
- ~19 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
NCT06735248
- Phase 2
- Ages 18 to 55 years
- Sex: All
Nearest site: Quest Research Institute (Farmington Hills, MI)
- Distance to nearest recruiting site
- ~20 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
NCT06846281
- Phase 3
- Ages 40 to 70 years
- Sex: All
Nearest site: Michigan Institute of Neurological (Farmington Hills, MI)
- Distance to nearest recruiting site
- ~20 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504
- Phase 3
- Ages 18 to 65 years
- Sex: All
Nearest site: Michigan Institute of Neurological (Farmington Hills, MI)
- Distance to nearest recruiting site
- ~20 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
NCT07325292
- Phase 3
- Ages 18 to 60 years
- Sex: All
Nearest site: Michigan Institute for Neurological Disorders- Site Number : 8400004 (Farmington Hills, MI)
- Distance to nearest recruiting site
- ~20 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
NCT07299019
- Phase 3
- Ages 18 to 60 years
- Sex: All
Nearest site: Profound Research LLC at Oakland Neurology Center (Rochester Hills, MI)
- Distance to nearest recruiting site
- ~23 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
NCT07002034
- Phase 2
- Ages 18 to 80 years
- Sex: All
Nearest sites: Henry Ford Health (Novi, MI); University of Michigan (Ann Arbor, MI)
- Distance to nearest recruiting site
- ~24 mi (city-level)
- Recruiting sites
- 2 sites within 50 mi
- Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
NCT05269628
- Phase 2
- Ages 18 to 65 years
- Sex: All
Nearest site: University of Michigan (Ann Arbor, MI)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
NCT06680037
- Phase 1
- Ages 18 years and older
- Sex: All
Nearest site: TG Therapeutics Investigational Trial Site (Ann Arbor, MI)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
- Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
NCT07392879
- Interventional
- Ages 18 years and older
- Sex: All
Nearest site: University of Michigan (Ann Arbor, MI)
- Distance to nearest recruiting site
- ~36 mi (city-level)
- Recruiting sites
- 1 site within 50 mi
FAQ
Common questions
What is a clinical trial?
Is there compensation for joining a Multiple Sclerosis clinical trial?
How do I check if I'm eligible?
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.